| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Owner
2 companies
Omega Fund VI, L.P. last filed a Form 4 in November 2023, as Former 10% Owner at SPRB. The filings on record cover 2 companies.
At the last filing, the largest reported position was 2,161,022 shares of SPRB. Net of sales, the SPRB filings show accumulation of 250,000 shares.
Omega Fund VI, L.P. has 2 Form 4 filings on record from October 2020 to November 2023, across 2 companies: 10% Owner at Lexeo Therapeutics (LXEO), 2023; Former 10% Owner at Spruce Biosciences (SPRB), 2020.
The 5 reported transactions were 3 conversions and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $8.7M and no sales.
The largest open-market purchase was 454,545 shares of LXEO at an average $11.00 on November 7, 2023, about $5.0M. Twelve months later LXEO was down 22%.
Shares as reported in the last Form 4 for each company; the most recent is from November 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.